Vistagen Therapeutics Statistics
Total Valuation
VTGN has a market cap or net worth of $10.67 million. The enterprise value is -$20.28 million.
| Market Cap | 10.67M |
| Enterprise Value | -20.28M |
Important Dates
The last earnings date was Friday, August 14, 2026, before market open.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
VTGN has 41.03 million shares outstanding. The number of shares has increased by 30.85% in one year.
| Current Share Class | 41.03M |
| Shares Outstanding | 41.03M |
| Shares Change (YoY) | +30.85% |
| Shares Change (QoQ) | +1.54% |
| Owned by Insiders (%) | 0.40% |
| Owned by Institutions (%) | 26.99% |
| Float | 38.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.27 |
| Forward PS | n/a |
| PB Ratio | 0.47 |
| P/TBV Ratio | 0.44 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.07, with a Debt / Equity ratio of 0.03.
| Current Ratio | 3.07 |
| Quick Ratio | 2.84 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -166.46% and return on invested capital (ROIC) is -103.20%.
| Return on Equity (ROE) | -166.46% |
| Return on Assets (ROA) | -83.21% |
| Return on Invested Capital (ROIC) | -103.20% |
| Return on Capital Employed (ROCE) | -283.86% |
| Weighted Average Cost of Capital (WACC) | 5.90% |
| Revenue Per Employee | $61,000 |
| Profits Per Employee | -$1.65M |
| Employee Count | 41 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, VTGN has paid $7,000 in taxes.
| Income Tax | 7,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -92.15% in the last 52 weeks. The beta is 0.38, so VTGN's price volatility has been lower than the market average.
| Beta (5Y) | 0.38 |
| 52-Week Price Change | -92.15% |
| 50-Day Moving Average | 0.37 |
| 200-Day Moving Average | 1.17 |
| Relative Strength Index (RSI) | 41.89 |
| Average Volume (20 Days) | 7,216,600 |
Short Selling Information
The latest short interest is 2.01 million, so 4.89% of the outstanding shares have been sold short.
| Short Interest | 2.01M |
| Short Previous Month | 1.60M |
| Short % of Shares Out | 4.89% |
| Short % of Float | 5.27% |
| Short Ratio (days to cover) | 0.52 |
Income Statement
In the last 12 months, VTGN had revenue of $2.50 million and -$67.62 million in losses. Loss per share was -$1.66.
| Revenue | 2.50M |
| Gross Profit | 2.50M |
| Operating Income | -69.67M |
| Pretax Income | -67.61M |
| Net Income | -67.62M |
| EBITDA | -69.46M |
| EBIT | -69.67M |
| Loss Per Share | -$1.66 |
Balance Sheet
The company has $31.73 million in cash and $783,000 in debt, with a net cash position of $30.95 million or $0.75 per share.
| Cash & Cash Equivalents | 31.73M |
| Total Debt | 783,000 |
| Net Cash | 30.95M |
| Net Cash Per Share | $0.75 |
| Equity (Book Value) | 24.48M |
| Book Value Per Share | 0.55 |
| Working Capital | 23.12M |
Cash Flow
In the last 12 months, operating cash flow was -$62.30 million and capital expenditures -$86,000, giving a free cash flow of -$62.38 million.
| Operating Cash Flow | -62.30M |
| Capital Expenditures | -86,000 |
| Depreciation & Amortization | 211,000 |
| Net Borrowing | -931,000 |
| Free Cash Flow | -62.38M |
| FCF Per Share | -$1.52 |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -2,785.69% |
| Pretax Margin | -2,703.44% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VTGN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -30.85% |
| Shareholder Yield | -30.85% |
| Earnings Yield | -633.83% |
| FCF Yield | -584.74% |
Analyst Forecast
The average price target for VTGN is $1.00, which is 284.62% higher than the current price. The consensus rating is "Hold".
| Price Target | $1.00 |
| Price Target Difference | 284.62% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 7, 2023. It was a reverse split with a ratio of 1:30.
| Last Split Date | Jun 7, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |